PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEsperion Therapeutics
Esperion Therapeutics(ESPR)
Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
NexletolBempedoic acid2020-02-212025-2040
Hypercholesterolemia
,
Dyslipidemias
,
Atherosclerosis
,
Hyperlipoproteinemia type ii
,
Familial combined hyperlipidemia
NexlizetBempedoic acid, Ezetimibe2020-02-262025-2040
Hypercholesterolemia
,
Dyslipidemias
,
Atherosclerosis
,
Hyperlipoproteinemia type ii
,
Familial combined hyperlipidemia
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Bempedoic acid
healthy volunteers/patients
,
diabetes mellitus
,
hypertension
,
hypertriglyceridemia
,
hiv infections
,
autosomal dominant polycystic kidney
,
hyperlipidemias
,
hyperlipoproteinemias
,
secondary prevention
,
hypercholesterolemia
,
cardiovascular diseases
,
atherosclerosis
,
dyslipidemias
,
type 2 diabetes mellitus
,
drug-related side effects and adverse reactions
,
acute coronary syndrome
,
st elevation myocardial infarction
,
myocardial infarction
,
hyperlipoproteinemia type ii
,
coronary artery disease
,
non-st elevated myocardial infarction
,
atherosclerotic plaque
,
metabolic diseases
,
lipid metabolism disorders
,
psoriatic arthritis
,
rheumatoid arthritis
,
carotid artery diseases
,
systemic lupus erythematosus
,
infarction
,
pregnancy
,
liver diseases
,
non-alcoholic fatty liver disease
,
fatty liver
,
stroke
,
transient ischemic attack
,
cerebral hemorrhage
Ezetimibe
pharmacokinetics
,
drug interactions
,
immunosuppression therapy
,
neoplasms
,
pharmacological phenomena
,
endometriosis
,
therapeutic equivalency
,
endometrial neoplasms
,
acute kidney injury
,
alopecia areata
,
alopecia
,
pancreatic ductal carcinoma
,
pancreatic neoplasms
,
neoplasm metastasis
,
healthy volunteers/patients
,
chronic hepatitis
,
chronic hepatitis d
,
hepatitis d
,
prostatic neoplasms
,
liver diseases
,
diabetic neuropathies
,
polyneuropathies
,
oxidative stress
,
lipidoses
,
homozygous familial hypercholesterolemia
,
hypertriglyceridemia
,
inborn errors lipid metabolism
,
inborn errors metabolism
,
essential hypertension
,
vascular diseases
,
aortic valve stenosis
,
pathologic constriction
,
secondary prevention
,
left ventricular hypertrophy
,
hypertrophy
,
diabetic nephropathies
,
infections
,
kidney transplantation
,
lung transplantation
,
communicable diseases
,
insulin resistance
,
carotid artery diseases
,
weight gain
,
hypercholesterolemia
,
dyslipidemias
,
coronary artery disease
,
hyperlipidemias
,
atherosclerosis
,
coronary disease
,
myocardial ischemia
,
cardiovascular diseases
,
heart diseases
,
type 2 diabetes mellitus
,
diabetes mellitus
,
hyperlipoproteinemias
,
hyperlipoproteinemia type ii
,
acute coronary syndrome
,
metabolic syndrome
,
hypertension
,
myocardial infarction
,
syndrome
,
infarction
,
ischemic stroke
,
kidney diseases
,
familial combined hyperlipidemia
,
hepatitis
,
hepatitis a
,
atherosclerotic plaque
,
stroke
,
peripheral arterial disease
,
chronic renal insufficiency
,
st elevation myocardial infarction
,
hepatitis c
,
inflammation
,
non-alcoholic fatty liver disease
,
lipid metabolism disorders
,
fatty liver
,
hiv infections
,
drug-related side effects and adverse reactions
,
peripheral vascular diseases
,
cognitive dysfunction
,
chronic hepatitis c
,
ischemia
,
type 1 diabetes mellitus
,
metabolic diseases
,
non-st elevated myocardial infarction
,
patient compliance
,
hiv
,
alcoholic fatty liver
,
glucose intolerance
,
renal insufficiency
,
preconception care
,
vitamin d deficiency
,
endocrine system diseases
,
nutritional and metabolic diseases
,
left ventricular dysfunction
,
vascular stiffness
,
transplantation
,
atrial fibrillation
,
magnetic resonance imaging
,
neuropsychology
,
hemostasis
,
arteriosclerosis
,
chronic disease
,
vascular calcification
,
calcinosis
,
carotid stenosis
,
intracranial arteriosclerosis
,
inferior wall myocardial infarction
,
stable angina
,
cerebrovascular disorders
,
hyperlipoproteinemia type v
,
lactation
,
genetic testing
,
hyperlipoproteinemia type iii
,
arthrogryposis
,
medication adherence
,
treatment adherence and compliance
,
motivational interviewing
,
compliance
,
intestinal diseases
,
prediabetic state
,
heart disease risk factors
,
cholecystitis
,
acalculous cholecystitis
,
alzheimer disease
,
obesity
,
covid-19
,
coronavirus infections
,
pregnancy
,
breast feeding
,
thrombocytopenic purpura idiopathic
,
thrombocytopenia
,
cerebral infarction
,
cerebral small vessel diseases
,
percutaneous coronary intervention
,
cardiomyopathies
,
transient ischemic attack
,
cerebral hemorrhage
,
computed tomography angiography
Mevalotin
progeria
,
syndrome
,
hiv infections
,
hyperlipidemias
,
hiv
,
hyperlipoproteinemias
,
cardiovascular diseases
,
hypercholesterolemia
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use